Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC
Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page
- Check3 days agoChange DetectedThe page metadata revision label was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedNo longer looking for participants was added, along with new help/join sections (How to Read a Study Record, Common Questions, How to Join a Study) and an Intervention/Treatment labeling update; the old Intervention / Treatment label was removed and the revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a refreshed version of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label on the page has been updated to v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's documentation or release tagging, without altering study content or navigation.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s revision/version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a technical or platform release rather than a change to the displayed clinical trial details.SummaryDifference0.1%

- Check74 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.